INS and Hypoglycemia: The AMPLITUDE-L and AMPLITUDE-S studies also reported significant reductions in HbA1c, FPG, and body weight compared with those of the placebo, with low rates of hypoglycemia, particularly in patients not using insulin or sulfonylureas [9].